Contact
searchSearch
HMP Global

From the Experts

Structural Heart Disease
Impact of TAVR on Functional vs. Degenerative Mitral Regurgitation
12/16/2025
Kayla Wong, BS; Jennifer Nguyen, BS, CCRC; Evan Walser-Kuntz, MS; Sara Olson, RN, CCRC; Le Nguyen, BS; Tremayne Ansani, BS; Andrew Willett, BS; Mario Gössl MD, PhD, MHA
This retrospective single-center study characterizes mitral regurgitation progression in 277 patients who underwent TAVR over a five-year follow-up period.
This retrospective single-center study characterizes mitral regurgitation progression in 277 patients who underwent TAVR over a five-year follow-up period.
This retrospective single-center...
12/16/2025
Cath Lab Digest
RDN & REIMBURSEMENT
Renal Denervation in Practice: A Conversation With Tai Kobayashi, MD
12/15/2025
Taisei J. Kobayashi, MD
"With CMS coverage finalized and private payers beginning to follow, renal denervation is poised to move from niche to mainstream," says Dr. Kobayashi. "The therapy’s safety profile is well established,(3,8) and now we have the infrastructure...
"With CMS coverage finalized and private payers beginning to follow, renal denervation is poised to move from niche to mainstream," says Dr. Kobayashi. "The therapy’s safety profile is well established,(3,8) and now we have the infrastructure...
"With CMS coverage finalized and...
12/15/2025
Cath Lab Digest
Program Spotlight
Advancing Interventional Cardiology at Baystate Medical Center With Next-Generation Imaging and Technology
12/09/2025
Amir Lotfi, MD; Andrew M. Goldsweig, MD
With a collaborative culture, high-volume expertise, and investment in cutting edge technology, Baystate Medical Center has become a nationally recognized leader in cardiovascular care. In the recent renovation and expansion of Baystate’s...
With a collaborative culture, high-volume expertise, and investment in cutting edge technology, Baystate Medical Center has become a nationally recognized leader in cardiovascular care. In the recent renovation and expansion of Baystate’s...
With a collaborative culture,...
12/09/2025
Cath Lab Digest
Clinical Editor's Corner
My Last Day in the Cath Lab: A Personal Reflection
12/05/2025
Morton J. Kern, MD, MSCAI, FACC, FAHA
On my last cath day, I was standing next to a freshly-minted first-year cardiology trainee. It was a bittersweet moment — a cliché, but true. How many fellows have I worked with? How many unusual patients and novel findings, and how many...
On my last cath day, I was standing next to a freshly-minted first-year cardiology trainee. It was a bittersweet moment — a cliché, but true. How many fellows have I worked with? How many unusual patients and novel findings, and how many...
On my last cath day, I was...
12/05/2025
Cath Lab Digest
Hemostasis
Beyond the Band: Evolving Solutions for Transradial Hemostasis
12/05/2025
Gautam Kumar, MD, FSCAI; Bailey Ann Richardson, NP-C, RNFA, CNOR, RCIS
As transradial access continues to dominate the interventional cardiology landscape, attention has increasingly shifted to optimizing post-procedural management, particularly radial artery closure.
As transradial access continues to dominate the interventional cardiology landscape, attention has increasingly shifted to optimizing post-procedural management, particularly radial artery closure.
As transradial access continues...
12/05/2025
Cath Lab Digest
Ask the Experts
Innovation That Overcomes Radial Access Challenges
11/01/2025
Manit Sabharwal ; Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
Long-term radialists Morton Kern, MD, and Arnold Seto, MD, MPA, discuss a novel radial access tool, the Prelude Wave™, with Merit Medical®’s Manit Sabharwal. Discussion ranges from transradial access clinical tips to the challenges of...
Long-term radialists Morton Kern, MD, and Arnold Seto, MD, MPA, discuss a novel radial access tool, the Prelude Wave™, with Merit Medical®’s Manit Sabharwal. Discussion ranges from transradial access clinical tips to the challenges of...
Long-term radialists Morton...
11/01/2025
Cath Lab Digest
Clinical Editor's Corner
Could Door to Lactate Clearance (DLC) in Shock Be the New Door-to-Balloon Time of STEMI?
10/31/2025
Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
Cardiogenic shock is clearly different than bacteremic, neurogenic, toxic, and traumatic (hypovolemic) shock. Significant research progress has been made just in arriving at a common language for shock, through the Society for Cardiovascular...
Cardiogenic shock is clearly different than bacteremic, neurogenic, toxic, and traumatic (hypovolemic) shock. Significant research progress has been made just in arriving at a common language for shock, through the Society for Cardiovascular...
Cardiogenic shock is clearly...
10/31/2025
Cath Lab Digest
Resistant Hypertension
Paradise™ Ultrasound Renal Denervation in Contemporary Practice
10/03/2025
Behnam N. Tehrani, MD, FSCAI
"The signal has been important and clinically meaningful," says Behnam Tehrani, MD. "At the 90-day visit, we have seen a median blood pressure reduction of over 30 mmHg systolic and 10 mmHg diastolic, with a median reduction of 1.3...
"The signal has been important and clinically meaningful," says Behnam Tehrani, MD. "At the 90-day visit, we have seen a median blood pressure reduction of over 30 mmHg systolic and 10 mmHg diastolic, with a median reduction of 1.3...
"The signal has been important...
10/03/2025
Cath Lab Digest
Clinical Editor's Corner
Do You Always Check the ACT Before Beginning PCI?
10/03/2025
Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI; Michael Ragosta, MD; Mir Basir, DO
The ACT should be in therapeutic range before disrupting a coronary artery. The rule is no guidewire insertion until ACT is in therapeutic range.
The ACT should be in therapeutic range before disrupting a coronary artery. The rule is no guidewire insertion until ACT is in therapeutic range.
The ACT should be in therapeutic...
10/03/2025
Cath Lab Digest
Device Access & Coverage
A Tale of Two Agencies: Medical Device Approval and Coverage in the United States
10/02/2025
Mehdi H. Shishehbor, DO, MPH, PhD; Ashkan Yahyavi, MD
The authors detail the challenging FDA approval and CMS coverage pathways for new medical devices and technologies, pinpoint key regulatory challenges, and offer targeted strategies to streamline adoption.
The authors detail the challenging FDA approval and CMS coverage pathways for new medical devices and technologies, pinpoint key regulatory challenges, and offer targeted strategies to streamline adoption.
The authors detail the...
10/02/2025
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

AI Plaque analysis
Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis
01/21/2026
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER,...
01/21/2026
Cath Lab Digest
AI Plaque analysis
Coverage Unlocks Reimbursable AI Plaque Quantification With Circle Cardiovascular Imaging's cvi42|Plaque
01/21/2026
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle...
01/21/2026
Cath Lab Digest
Acquisitions
Haemonetics Acquires Vivasure Medical Limited
01/21/2026
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite...
01/21/2026
Cath Lab Digest
Early CAD Detection
Mammograms and Hidden Heart Disease: Annual Scans Can Detect This Silent Killer and Help Save Lives, but Awareness Is Key
01/21/2026
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast...
01/21/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Demonstrates Ability to Offer Interventional Physicians Unmatched Level of Radiation Protection Thanks to First-of-Its-Kind NOVARAD Clinical Study
01/21/2026
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD...
01/21/2026
Cath Lab Digest
Technology & Health Literacy
ECRI: Misuse of AI Chatbots Tops Annual List of Health Tech Hazards
01/21/2026
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots...
01/21/2026
Cath Lab Digest
CAD Risk Factors
North Carolina State University Study Finds Police-Related Stress Associated With Physical Markers of Cardiovascular Health Risk for Black Women
01/19/2026
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related...
01/19/2026
Cath Lab Digest
Acquisitions
Boston Scientific Announces Agreement to Acquire Penumbra, Inc.
01/15/2026
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA,...
01/15/2026
Cath Lab Digest
Radiation Safety
Rampart Launches SECURE Clinical Program to Advance Clinical Evidence for Next Generation Radiation Protection
01/08/2026
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind,...
01/08/2026
Vascular Disease Management
Mitral Valve Intervention
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
01/05/2026
The SAPIEN M3 transcatheter mitral valve replacement (TMVR) system is indicated for the treatment of symptomatic moderate-to-severe or severe MR in patients who are deemed unsuitable for surgery or transcatheter edge-to-edge repair (TEER)...
The SAPIEN M3 transcatheter mitral valve replacement (TMVR) system is indicated for the treatment of symptomatic moderate-to-severe or severe MR in patients who are deemed unsuitable for surgery or transcatheter edge-to-edge repair (TEER)...
The SAPIEN M3 transcatheter...
01/05/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use